OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
-14.36%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.29%
AUM
$203M
AUM Growth
+$203M
(-19%)
Cap. Flow
-$16.4M
Cap. Flow
% of AUM
-8.05%
Top 10 Holdings %
Top 10 Hldgs %
43.02%
Holding
56
New
10
Increased
13
Reduced
13
Closed
7
Top Buys
| 1 |
Indaptus Therapeutics
INDP
|
$3.53M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$2.77M |
| 3 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$2.63M |
| 4 |
TG Therapeutics
TGTX
|
$2.62M |
| 5 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$2.27M |
Top Sells
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$8.94M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$7.91M |
| 3 |
MiMedx Group
MDXG
|
$7.15M |
| 4 |
CMRX
Chimerix, Inc.
CMRX
|
$4.97M |
| 5 |
CEMP
Cempra, Inc.
CEMP
|
$3.62M |
Sector Composition
| 1 | Healthcare | 80.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMRX
1
DELISTED
Chimerix, Inc.
CMRX
| $11.8M | 5.83% | 310,000 -130,000 | -30% | -$4.97M |
|
2
Ultragenyx Pharmaceutical
RARE
$2.89B
| $10.6M | 5.21% | 110,000 | – | – |
|
|
CEMP
3
DELISTED
Cempra, Inc.
CEMP
| $10M | 4.93% | 360,000 -130,000 | -27% | -$3.62M |
|
4
Axogen
AXGN
$743M
| $8.73M | 4.3% | 2,120,000 | – | – |
|
|
GNMX
5
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $8.28M | 4.07% | 1,058,400 +8,400 | +0.8% | +$65.7K |
|
|
AMAG
6
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $7.95M | 3.91% | 200,000 +10,000 | +5% | +$397K |
|
7
Harrow
HROW
$1.44B
| $7.74M | 3.81% | 1,205,000 | – | – |
|
|
ARIA
8
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $7.65M | 3.76% | 1,310,000 -190,000 | -13% | -$1.11M |
|
9
Travere Therapeutics
TVTX
$1.56B
| $7.5M | 3.69% | 370,000 -90,000 | -20% | -$1.82M |
|
10
FibroGen
FGEN
$47.8M
| $7.12M | 3.51% | 325,000 | – | – |
|
11
Supernus Pharmaceuticals
SUPN
$2.53B
| $6.45M | 3.18% | 460,000 -75,000 | -14% | -$1.05M |
|
|
ZSPH
12
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $6.24M | 3.07% | 95,000 | – | – |
|
|
TVRD
13
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $5.93M | 2.92% | 415,000 +75,000 | +22% | +$1.07M |
|
14
Codexis
CDXS
$246M
| $5.49M | 2.7% | 1,620,000 -104,000 | -6% | -$353K |
|
|
EGRX
15
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.42M | 2.67% | 73,200 +23,200 | +46% | +$1.72M |
|
|
AVDL
16
Avadel Pharmaceuticals
AVDL
$1.43B
| $5.06M | 2.49% | 310,000 | – | – |
|
17
Geron
GERN
$893M
| $5.04M | 2.48% | 1,825,000 | – | – |
|
18
Neurocrine Biosciences
NBIX
$13.8B
| $4.97M | 2.45% | 125,000 -20,000 | -14% | -$796K |
|
|
ISEE
19
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $4.26M | 2.09% | 105,000 | – | – |
|
|
AFMD
20
DELISTED
Affimed
AFMD
| $3.64M | 1.79% | 590,300 | – | – |
|
|
21
Indaptus Therapeutics
INDP
$7.19M
| $3.53M | 1.74% | +630,000 | New | +$3.53M |
|
|
AMRN
22
Amarin Corp
AMRN
$311M
| $3.4M | 1.67% | 1,760,000 +6,000 | +0.3% | +$11.6K |
|
|
ZGNX
23
DELISTED
Zogenix, Inc.
ZGNX
| $3.38M | 1.66% | 250,000 -662,500 | -73% | -$8.94M |
|
|
TRIL
24
DELISTED
Trillium Therapeutics Inc.
TRIL
| $3.2M | 1.57% | 245,275 -4,725 | -2% | -$61.6K |
|
25
Tonix Pharmaceuticals
TNXP
$260M
| $3.02M | 1.48% | 570,000 +380,000 | +200% | +$2.01M |
|